evaluation of the effect of Novafen and Gelofen in post canal treatment pain decrement
- Conditions
- Pharmacokinetics.Other and unspecified diseases of pulp and periapical tissues
- Registration Number
- IRCT2014041316973N2
- Lead Sponsor
- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
1.The patient should be able to read , understand and complete the consent form; 2.Patient's consent form has been completed; 3.Teeth with a live pulp that do not have a peri-apical lesion should have been evaluated.
Exclusion criteria :
1.Pregnancy; 2.Hypersensitivity to NSAIDs and Sulfonamides; 3.History of asthma associated with nasal polyps; 4.History of chronic use of analgesics or sedatives; 5.Alcohol abuse; 6.Patients with uncontrolled hypertension; 7.Diabetes mellitus; 8.Renal disease, CNS disease, heart disease and liver dysfunction; 9.Cancer or major anomalies confirmed by clinical examinations or laboratory findings; 10.Aged less than 18 and more than 65; 11.Pregnancy or breastfeeding; 12.Analgesic use less than 12 hours to the beginning of the study.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: One hour before treatment. Method of measurement: 4,8,12,24,48.
- Secondary Outcome Measures
Name Time Method